MAPT and dementia: This study identified circadian rhythms as potential modifiable risk factors that could be targeted with circadian-based therapies to attenuate pathological progression of Aβ and tau in the brain, and in turn prevent or slow the transition into MCI and dementia for at-risk older adults.